Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:35:03 EDT Tue 22 Oct 2024
Enter Symbol
or Name
USA
CA



Q:NKTX - NKARTA INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NKTX - Q0.14.18·4.700.14.22-0.04-0.9740.02,9993,9254.27  4.545  4.1816.24  1.81Oct 21Sep 0315 min RT 2¢

Recent Trades - Last 10 of 3925
Time ETExPriceChangeVolume
16:06:54Q4.19-0.071
16:02:06Q4.22-0.04221
16:01:44Q4.22-0.04438
16:01:41Q4.22-0.04252
16:00:09Q4.22-0.04311
16:00:09Q4.22-0.0415
16:00:07Q4.22-0.04127
16:00:01Q4.22-0.04180
16:00:00Q4.22-0.04200
16:00:00Q4.22-0.0428

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-09-03 16:01U:NKTXNews ReleaseNkarta to Participate in Upcoming Investor Conference
2024-08-13 21:04U:NKTXNews ReleaseCorrection: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
2024-08-13 16:01U:NKTXNews ReleaseNkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
2024-07-24 06:00U:NKTXNews ReleaseNkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus
2024-07-16 06:01U:NKTXNews ReleaseNkarta Announces Leadership Updates, Appoints Nadir Mahmood as President
2024-06-27 06:00U:NKTXNews ReleaseNkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
2024-06-13 16:01U:NKTXNews ReleaseNkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
2024-05-09 16:01U:NKTXNews ReleaseNkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
2024-04-03 16:02U:NKTXNews ReleaseNkarta to Participate in Upcoming Investor Conferences
2024-03-25 06:30U:NKTXNews ReleaseNkarta Announces Pricing of $240 Million Underwritten Offering
2024-03-21 16:01U:NKTXNews ReleaseNkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
2024-02-28 08:01U:NKTXNews ReleaseNkarta to Participate in Upcoming Investor Conferences
2024-01-09 10:25U:NKTXNews ReleaseGlobal Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
2023-12-09 20:31U:NKTXNews ReleaseNkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
2023-11-09 16:02U:NKTXNews ReleaseNkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
2023-11-07 08:02U:NKTXNews ReleaseNkarta to Participate at Upcoming Investor Conferences